Escape of pathogens from the host immune response by mutations and mimicry. Possible means to improve vaccine performance

Medical Hypotheses
Gerard Berger

Abstract

The ability of certain pathogens, such as human immunodeficiency, hepatitis C, herpes simplex, influenza viruses, Plasmodium falciparum, etc., to escape from host immune response is generally ascribed to high mutation rate of their genome. We challenge this assumption and propose that molecular mimicry of host antigens by these pathogens could also participate to this resistance. Several studies show that there is no correlation between the mutation rate value of a pathogen and the possibility to develop an effective vaccine. On the other hand, pathogens which do not respond to vaccine are usually reported to display host protein mimicry. We propose to suppress in the thymus the epitopes of the self which are in common with the pathogen. This could be achieved by intrathymic injection of antibodies against this microorganism. These antibodies would be obtained by vaccination of a foreign animal species. It is expected that the negative selection of the CD4(+) and CD8(+) T lymphocytes specific for these epitopes would be prevented, that the number of epitopes recognized as foreign to the host would be increased and that the immune response diversity would be enhanced.

References

Apr 15, 1991·Biochimica Et Biophysica Acta·A Husain-Chishti, P Ruff
Apr 7, 1983·The New England Journal of Medicine·R ElieW S Lapp
Oct 1, 1993·AIDS Research and Human Retroviruses·M EddlestonM B Oldstone
Jun 1, 1994·Immunology Today·S K AhujaP M Murphy
Aug 1, 1996·Journal of the Neurological Sciences·M MatsuiY Kuroda
Aug 1, 1997·Molecular Biology and Evolution·Y Suzuki, T Gojobori
Aug 1, 1997·Psychiatry and Clinical Neurosciences·Y Hayase, K Tobita
Jan 1, 1997·Intervirology·T K Frey
Apr 18, 1998·Biochimica Et Biophysica Acta·R Ramasamy
Jul 23, 1999·Annals of the New York Academy of Sciences·J W Drake
Nov 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·J W Drake, J J Holland
Feb 26, 2000·Vaccine·D C Douek, R A Koup
Feb 15, 2001·The New England Journal of Medicine·A AscherioA M Walker
Feb 28, 2001·Virus Research·V R WellsJ J DeStefano
Mar 7, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S ZucchelliA Nicosia
Jun 8, 2001·Parasitology·S Paget-McNicol, A Saul
Sep 6, 2001·Proceedings of the National Academy of Sciences of the United States of America·S M MacDonaldS R Meshnick
Sep 6, 2001·Journal of Neuroscience Research·C Besson DuvanelJ M Matthieu
May 7, 2002·Journal of Virology·Qiaosheng LuCharles B C Hwang
Oct 5, 2002·Clinics in Liver Disease·Arndt VogelChristian P Strassburg
Nov 1, 2003·Virology·Glòria SánchezRosa M Pintó
Nov 30, 2004·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Amir Z MaksyutovZaki A Maksyutov
Jan 25, 2005·Journal of Virological Methods·K J Huang, D P Wooley
Feb 1, 2005·Virology·Yu-Wen HuEarl G Brown
Apr 2, 2005·Genetics·John W Drake, Charles B C Hwang

❮ Previous
Next ❯

Citations

Oct 23, 2016·Vaccine·Anthony L CunninghamPeter Stern
May 10, 2020·Molecular Psychiatry·Charlotte SteenblockStefan R Bornstein

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.